ChemoCentryx Inc

+1.55 (+4.37%)
Earnings Announcements

ChemoCentryx Reports Qtrly Loss Per Share $0.32

Published: 11/09/2021 22:48 GMT
ChemoCentryx Inc (CCXI) - Chemocentryx Reports Third Quarter 2021 Financial Results and Recent Highlights.
Q3 Revenue $17.7 Million.
$372 Million in Cash and Investments at September 30, 2021.
Expects to End Year With Cash, Cash Equivalents and Investments in Excess of $360 Million.
Qtrly Loss per Share $0.32.
Q3 Earnings per Share View $-0.45, Revenue View $13.5 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $21.43 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $7.62 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.